AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $78,346,000 | +65.2% | 1,309,250 | -22.5% | 0.01% | +25.0% |
| Q3 2019 | $47,433,000 | -32.5% | 1,688,616 | -9.0% | 0.00% | -20.0% |
| Q2 2019 | $70,262,000 | +30.0% | 1,855,826 | +34.0% | 0.01% | +25.0% |
| Q1 2019 | $54,060,000 | +55.4% | 1,385,442 | -15.1% | 0.00% | +33.3% |
| Q4 2018 | $34,794,000 | -31.4% | 1,631,971 | +27.5% | 0.00% | -25.0% |
| Q3 2018 | $50,694,000 | +1.3% | 1,280,443 | -2.2% | 0.00% | 0.0% |
| Q2 2018 | $50,036,000 | +67.4% | 1,309,504 | +31.6% | 0.00% | +33.3% |
| Q1 2018 | $29,893,000 | +66.7% | 994,770 | +73.3% | 0.00% | +200.0% |
| Q4 2017 | $17,937,000 | +153.7% | 573,961 | +127.5% | 0.00% | 0.0% |
| Q3 2017 | $7,070,000 | +67.0% | 252,284 | +14.0% | 0.00% | – |
| Q2 2017 | $4,234,000 | +272.4% | 221,276 | +231.6% | 0.00% | – |
| Q1 2017 | $1,137,000 | -1.2% | 66,732 | +6.0% | 0.00% | – |
| Q4 2016 | $1,151,000 | +82.1% | 62,980 | +77.4% | 0.00% | – |
| Q3 2016 | $632,000 | – | 35,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |